This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Vantive is investing $1bn towards advancing its kidney care and vital organ supp...
Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation ...
A new EU consortium has launched with the aim to reduce pancreatic cancer mortal...
Harbinger Health has reported clinical data at the American Society of Clinical ...
The US Food and Drug Administration (FDA) has granted breakthrough device design...
The UK National Health Service (NHS) England has rolled out a new liquid biopsy ...
Danaher Corporation has announced a collaboration with AstraZeneca for diagnosti...
Spring steel is undergoing a transformation as high-performance engineering dema...
New research has shown that the ArteraAI test can help identify which men with n...
Acclaro Medical has completed a Series B funding round, raising $23m, to spur th...
Moximed has announced the treatment of the first subject in the MOTION randomise...
HistoSonics' Edison histotripsy system has been granted controlled early limited...
Helix has released a new suite of pharmacogenomics (PGx) tests, widening its por...
Illumina is expanding access to its oncology range of IVD tests, as its TruSight...
The FDA has granted 510(k) clearance for Distalmotion’s DEXTER robotic surgery s...
The US structural heart occlusion (SHO) market recorded a strong 39% year-over-y...
BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Athe...
The CEO of Flow Neuroscience has called out the US Food and Drug Administration ...
NeuroPace has reported the initial primary endpoint one-year outcomes from the N...
Danish medtech Brainreader has secured $7.3m (€6.6m) to support the market rollo...
SAGA Diagnostics has commercially launched the multi-cancer molecular residual d...
The US Food and Drug Administration (FDA) has granted approval for Abbott's Tend...
The 12th Outsourcing in Clinical Trials UK & Ireland conference will focus on th...
Salvia BioElectronics has raised €53m ($60m) in Series B funding towards advanci...